|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
Laboratory Report
|
|
|
|||||||||||||||||||||||||
Hematology
| Test | 25-MAY-2017 | Reference Range | Unit |
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 9.2 | 4 - 11 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 5.8 H | 3.8 - 5.7 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 13.4 | 12 - 16 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 47.6 | 38 - 56 | % |
| MCV [Entitic volume] by Automated count | 90.6 | 78 - 98 | fL |
| MCH [Entitic mass] by Automated count | 30.8 | 27 - 34 | pg |
| MCHC [Mass/volume] by Automated count | 33.4 | 32 - 35 | g/dL |
| Erythrocyte distribution width [Ratio] by Automated count | 13.6 | 11.6 - 16.5 | % |
| Platelets [#/volume] in Blood by Automated count | 376.0 | 157 - 415 | 10*3/uL |
Chemistry
| Test | 25-MAY-2017 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 71.5 | 70 - 99 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 7.8 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.9 H | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 9.7 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 136.6 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 4.3 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 105.0 | 98 - 108 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 23.3 | 22 - 32 | mmol/L |
| Protein [Mass/volume] in Serum or Plasma | 7.8 | 6 - 8.3 | g/dL |
| Albumin [Mass/volume] in Serum or Plasma | 4.5 | 3.5 - 5 | g/dL |
| Bilirubin.total [Mass/volume] in Serum or Plasma | 11.8 H | 0.3 - 1.2 | mg/dL |
| Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 46.2 | 32 - 150 | U/L |
| Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22.8 | 13 - 32 | U/L |
| Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 16.4 | 10 - 40 | U/L |
| Magnesium [Mass/volume] in Serum or Plasma | 2.0 | 1.7 - 2.6 | mg/dL |
| Phosphate [Mass/volume] in Serum or Plasma | 3.2 | 2.5 - 4.5 | mg/dL |
| pH of Arterial blood | 7.1 L | 7.35 - 7.45 | [pH] |
| Carbon dioxide [Partial pressure] in Arterial blood | 35.0 L | 38 - 48 | mm[Hg] |
| Oxygen [Partial pressure] in Arterial blood | 94.3 | 75 - 100 | mm[Hg] |
| Bicarbonate [Moles/volume] in Arterial blood | 25.6 | 22 - 31 | mmol/L |
| Oxygen saturation in Arterial blood | 94.0 L | 95 - 100 | % |
| Cholesterol [Mass/volume] in Serum or Plasma | 299.5 H | 130 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 140.8 | 0 - 199 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 210.5 H | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 60.9 | 50 - 100 | mg/dL |
Coagulation
| Test | 25-MAY-2017 | Reference Range | Unit |
|---|---|---|---|
| Prothrombin time (PT) | 9.9 L | 11 - 15 | s |
| INR in Platelet poor plasma by Coagulation assay | 2.4 H | 0.9 - 1.1 | {INR} |
| aPTT in Blood by Coagulation assay | 34.1 | 25 - 35 | s |
Annotation
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows elevated creatinine, indicating impaired renal function, and markedly increased total bilirubin, suggesting possible liver dysfunction or hemolysis. INR is elevated with a low PT, which may reflect anticoagulation therapy or lab artifact. Arterial blood gas reveals acidemia (pH 7.1) with low pCO₂ and mild hypoxemia. Lipid profile shows significant hypercholesterolemia and high LDL. Erythrocyte count is slightly elevated. Overall, findings suggest renal impairment, metabolic acidosis, hyperlipidemia, and possible hepatic or hematologic pathology; clinical correlation and further evaluation are recommended. |